Morgan Stanley (NYSE:MS) initiated coverage on shares of GlaxoSmithKline (NYSE:GSK:LN) (NYSE: GSK), a $72.5 billion pharmaceutical giant with a 25-year track record of consistent dividend payments, ...

Sentiment plummeted to a seven-month low as one-year inflation expectations surged to their highest point since late 2023. The US economy added 143,000 jobs in January, fewer than expected. The ...

GSK PLC closed 20.84% below its 52-week high of £18.24, which the company achieved on May 16th.

Key Insights Significantly high institutional ownership implies GSK's stock price is sensitive to their trading ...

Shares of British pharmaceutical giant GSK surged on Wednesday after the company raised its long-term sales forecast and ...

SAN DIEGO, CA / ACCESS Newswire / February 10, 2025 / Robbins LLP reminds stockholders that a class action was filed on ...

GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...

Shares of GSK PLC GSK advanced 1.56% to £14.66 Monday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.77% to 8,767.80. GSK PLC ...

Check the time stamp on this data. Updated AI-Generated Signals for Gsk Plc American Depositary Shares (each Representing Two ...